C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2011
08/18/2011	US20110201547 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
08/18/2011	US20110201540 Glycosylation of Molecules
08/18/2011	US20110201518 Healthy kidney biomarkers
08/18/2011	US20110201104 Antiviral agent against animal viruses
08/18/2011	US20110201080 Biomolecules having multiple attachment moieties for binding to a substrate surface
08/18/2011	US20110201035 Compositions and methods for the detection of hiv-1/hiv-2 infection
08/18/2011	US20110201033 G immunoglobulin used against anthrax toxins
08/18/2011	US20110201030 Human G-Protein Chemokine Receptor (CCR5) HDGNR10
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110201023 Mannose 6-phosphate-binding antibodies and their uses
08/18/2011	US20110201021 Use of the irap protein for implementing methods of diagnosis and of prognosis
08/18/2011	US20110201014 Antibody binding to envelope protein 2 of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same
08/18/2011	US20110201003 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin
08/18/2011	US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B
08/18/2011	US20110200629 Tumor antigen peptide and use thereof
08/18/2011	US20110200627 Anti-cd147 antibodies, methods and uses
08/18/2011	US20110200615 Antibodies that Neutralize Botulinum Neurotoxins
08/18/2011	US20110200614 Anthrax specific antibodies
08/18/2011	US20110200613 Use of B Cell Expansion Agents in Generating Antibodies
08/18/2011	US20110200611 Plasma kallikrein binding proteins
08/18/2011	US20110200610 Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders
08/18/2011	US20110200609 Monoclonal antibodies specific for pathological amyloid aggregates common to amyloids formed from proteins of differing sequence
08/18/2011	US20110200608 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
08/18/2011	US20110200606 Antibodies that Bind to Lysyl Oxidase-Like 2 (LOXL2) and Methods of Use Therefor
08/18/2011	US20110200605 Polypeptides and use thereof
08/18/2011	US20110200604 IDENTIFICATION OF NOVEL IgE EPITOPES
08/18/2011	US20110200603 New antigens for paratuberculosis diagnosis and vaccination
08/18/2011	US20110200602 Antibodies to egfl7 and methods for their use
08/18/2011	US20110200601 Drug Delivery to Human Tissues by Single Chain Variable Region Antibody Fragments Cloned by Phage Display
08/18/2011	US20110200596 Monovalent antibody fragments useful as therapeutics
08/18/2011	US20110200594 Functionalized polypeptides
08/18/2011	US20110200591 Products and methods to prevent infections
08/18/2011	US20110200590 Antibodies Directed Against the Myelin Basic Protein Recognising an Epitope of CD64 and Their Use as Immunosuppressants
08/18/2011	US20110200589 Deconvolution method
08/18/2011	US20110200585 Cd127 binding proteins
08/18/2011	US20110200579 Novel gene disruptions, compositions and methods relating thereto
08/18/2011	US20110200536 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
08/18/2011	US20110200525 Vhh antibody fragments for use in the detection and treatment of cancer
08/18/2011	CA2789623A1 Therapeutic methods using anti-cd200 antibodies
08/18/2011	CA2789560A1 Preparation and/or purification of oligonucleotide conjugates
08/18/2011	CA2789505A1 Free hexasaccharide isolated from several campylobacter species
08/18/2011	CA2789416A1 Novel uses
08/18/2011	CA2789310A1 Radioactive metal-labeled anti-cadherin antibody
08/18/2011	CA2789251A1 Agonist dr5 binding polypeptides
08/18/2011	CA2788758A1 Treatment of a metabolic disorder
08/18/2011	CA2788400A1 Antibodies against cxcr4
08/18/2011	CA2787897A1 Single unit antibody purification
08/17/2011	EP2357478A2 Diagnosis of disease
08/17/2011	EP2357476A2 Detection and measurement of blood-feeding activity
08/17/2011	EP2357250A2 Production of polypeptides
08/17/2011	EP2357238A2 Compositions and methods for regulation of tumor necrosis factor-alpha
08/17/2011	EP2357237A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
08/17/2011	EP2357202A1 Targeted binding agents directed to Upar and uses thereof
08/17/2011	EP2357201A1 Anti-P-selectin antibodies
08/17/2011	EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011	EP2357199A1 Antibody against n-terminal region of -chain of hemoglobin
08/17/2011	EP2357198A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/17/2011	EP2357197A1 Anti-HPV E7 antibodies
08/17/2011	EP2357196A2 Immunoglobulin chimeric monomer-dimer hybrids
08/17/2011	EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same
08/17/2011	EP2357187A1 Molecules with extended half-lives, compositions and uses thereof
08/17/2011	EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
08/17/2011	EP2357008A1 Albumin fusion proteins
08/17/2011	EP2357006A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
08/17/2011	EP2357005A1 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
08/17/2011	EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods
08/17/2011	EP2357003A2 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
08/17/2011	EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation
08/17/2011	EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011	EP2356251A1 Teneurin and cancer
08/17/2011	EP2356239A2 Gi-igg intron for enhanced anti-igf1 r expression
08/17/2011	EP2356238A2 Nurr1 interacting protein (nuip)
08/17/2011	EP2356224A1 Methods of inhibiting inflammation-associated tissue damage by inhibiting neutrophil activity
08/17/2011	EP2356216A2 Papio cynocephalus toll-like receptor 3
08/17/2011	EP2356154A1 Engineered antibodies with reduced immunogenicity and methods of making
08/17/2011	EP2356153A2 Cross-species-specific psmaxcd3 bispecific single chain antibody
08/17/2011	EP2356152A1 Anti-tgf-beta receptor ii antibodies
08/17/2011	EP2356151A1 High affinity human antibodies to human il-4 receptor
08/17/2011	EP2356150A2 Tcr complex immunotherapeutics
08/17/2011	EP2356149A2 Ligands that have binding specificity for dc-sign
08/17/2011	EP2356148A2 Antibodies to modified human igf-1/e peptides
08/17/2011	EP2356147A1 Polypeptides, antibody variable domains&antagonists
08/17/2011	EP2356146A1 Anti-dll4 antibodies and uses thereof
08/17/2011	EP2356145A2 Fully human antibodies against n-cadherin
08/17/2011	EP2356144A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
08/17/2011	EP2356143A1 Vaccine compositions
08/17/2011	EP2356135A1 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
08/17/2011	EP2356131A1 Masking ligands for reversible inhibition of multivalent compounds
08/17/2011	EP2355850A2 N-cadherin: target for cancer diagnosis and therapy
08/17/2011	EP2355849A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
08/17/2011	EP2355848A2 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases
08/17/2011	EP2355847A1 Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1)
08/17/2011	EP2355843A1 Vaccine for the prevention of breast cancer recurrence
08/17/2011	EP2355841A1 Immunization protocol for directed expansion and maturation
08/17/2011	EP1870421B1 Anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
08/17/2011	EP1677112B1 Immunoassay
08/17/2011	EP1578936B1 Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors
08/17/2011	EP1571970B1 Diagnosis and monitoring of diseases
08/17/2011	EP1562571B1 Combination of a diamide derivative and immunosuppressive agents for inhibiting transplant rejection
08/17/2011	EP1328547B1 Identification and modification of immunodominant epitopes in polypeptides

1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 1494